v3.26.1
RECAPITALIZATION (Tables)
 12 Months Ended
Dec. 31, 2025
Recapitalization  
SCHEDULE OF RECONCILES THE ELEMENTS OF THE BUSINESS COMBINATION

 

      
Cash-trust and cash, net of redemptions  $811,370 
Less: transaction costs, paid   (545,543)
Net proceeds from the Reverse Recapitalization   265,827 
      
Less: accounts payable, accrued liabilities and other current liabilities combined   (1,577,057)
Less: Promissory note fee – related party combined   (1,000,000)
Less: Subscription agreement loans combined   (1,828,098)
Less: Loan and transfer note payable combined   (499,214)
Less: Forward purchase agreement liability combined   (49,034)
      
Add: other assets, net   85,000 
Reverse recapitalization, net  $(4,602,576)
SCHEDULE OF CONSUMMATION OF THE BUSINESS COMBINATION

The number of shares of Common Stock issued immediately following the consummation of the Reverse Recapitalization were:

 

      
PowerUp Class A common stock, outstanding prior to the Reverse Recapitalization   7,765,144 
Less: Redemption of PowerUp Class A common stock   (507,631)
Class A common stock of PowerUp   7,257,513 
PowerUp Class B common stock, outstanding prior to the Reverse Recapitalization   — 
Reverse Recapitalization Class A common stock, before giving effect to the 1-for-40 reverse split   7,257,513 
Reverse Recapitalization Class A common stock, after giving effect to the 1-for-40 reverse split   181,438 
Issuance of shares related working capital agreements   93,750 
Aspire Biopharma, Inc. Shares   875,000 
Common Stock immediately after the Reverse Recapitalization, after giving effect to the 1-for-40 reverse split   1,150,188 
SCHEDULE OF NUMBER OF SHARES CONVERSION RATIO

The number of Aspire Biopharma, Inc. shares was determined as follows after giving effect to the Reverse Split described in Note 3:

 

   Aspire Biopharma, Inc Shares   Aspire’s Shares after conversion ratio 
Common Stock issued to existing Aspire Biopharma, Inc. Shareholders   13,295,551    833,437 
Common Stock obligation shares issued   —    41,563 
Number of Shares   13,295,551    875,000